Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study

PURPOSE: We determined the feasibility of substituting sitagliptin or mitiglinide for bolus insulin injection therapy in patients with type 2 diabetes. METHODS: 60 patients with type 2 diabetes were enrolled and randomized to switch from mealtime dosing of a rapid-acting insulin analog to either sit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open Diabetes Res Care
Glavni autori: Takeshita, Yumie, Takamura, Toshinari, Kita, Yuki, Takazakura, Akiko, Kato, Ken-ichiro, Isobe, Yuki, Kaneko, Shuichi
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2015
Teme:
Clinical Care/Education/Nutrition/Psychosocial Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4553908/
https://ncbi.nlm.nih.gov/pubmed/26336611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2015-000122
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items